MOSCOW, January 31. /TASS/. The Gamaleya Center has filed documents with the Russian Health Ministry to register a vaccine against coronavirus which will be used to inoculate children aged 6-11, the center’s director, Alexander Gintsburg, told TASS on Tuesday.

"Yes, I filed the paperwork," he said, replying to a question on the matter.

The relevant information on the documents filed has also been published in the state register of medicinal substances. It is noted that the shot will consist of two doses. "Trade name: Gam-COVID-vac-D, a combined vector vaccine for the prevention of the coronavirus infection caused by the SARS-СoV-2 virus. A solution for intramuscular administration, Component I (0.5 ml per dose) plus Component II (0.5 ml per dose). Shelf life: 15 months," according to the register’s data.

On January 24, 2022, the Russian Health Ministry approved clinical trials of a vaccine against coronavirus developed by the Gamaleya Center among children aged 6-11.